Showing 1 - 11 results of 11 for search 'Pascal Pommier', query time: 3.56s Refine Results
  1. 1
    Hypofractionated stereotactic boost in intermediate risk prostate carcinoma: Preliminary results of a multicenter phase II trial (CKNO-PRO).

    Hypofractionated stereotactic boost in intermediate risk prostate carcinoma: Preliminary results of a multicenter phase II trial (CKNO-PRO). by David Pasquier, Philippe Nickers, Didier Peiffert, Philippe Maingon, Pascal Pommier, Thomas Lacornerie, Geoffrey Martinage, Emmanuelle Tresch, Eric Lartigau

    Published 2017-01-01
    Get full text
    Article
  2. 2
    A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO Trial

    A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the C... by David Pasquier, Philippe Nickers, Didier Peiffert, Philippe Maingon, Pascal Pommier, Thomas Lacornerie, Emmanuelle Tresch, Maël Barthoulot, Eric Lartigau

    Published 2023-08-01
    Get full text
    Article
  3. 3
    Resident training in brachytherapy in France: A 10-year update after the first survey of SFJRO members

    Resident training in brachytherapy in France: A 10-year update after the first survey of SFJRO members by Manon Kissel, Luc Ollivier, Ingrid Fumagalli, Pascal Pommier, Cyrus Chargari, Pierre Blanchard, Didier Peiffert, Jean-Michel Hannoun-Levi

    Published 2022-12-01
    Get full text
    Article
  4. 4
    Combined intra-cavitary and interstitial image-guided adaptative brachytherapy for cervical stump carcinomas: technical and clinical results of six patients

    Combined intra-cavitary and interstitial image-guided adaptative brachytherapy for cervical stump carcinomas: technical and clinical results of six patients by Florent Guillemin, Anne-Agathe Serre, Frédéric Gassa, Fabrice Lorchel, Magali Sandt, Frédéric Lafay, Julien Charret, Corinne Rannou, Pascal Pommier

    Published 2022-05-01
    Get full text
    Article
  5. 5
    Eligibility criteria according to EAU/ESTRO/SIOG guidelines for exclusive iodine-125 brachytherapy for intermediate-risk prostate adenocarcinoma patients: impact on relapse-free survival

    Eligibility criteria according to EAU/ESTRO/SIOG guidelines for exclusive iodine-125 brachytherapy for intermediate-risk prostate adenocarcinoma patients: impact on relapse-free su... by Sophie Robin, Sylvie Chabaud, Anne-Agathe Serre, Béatrice Bringeon, Sébastien Clippe, François Rocher, Olivier Desmettre, Gabriel Bringeon, Frédéric Gassa, Pascal Pommier

    Published 2021-08-01
    Get full text
    Article
  6. 6
    Salvage brachytherapy with or without external beam radiotherapy for oral or oropharyngeal squamous cell carcinomas in previously irradiated areas: carcinologic and toxicity outcomes of 25 patients

    Salvage brachytherapy with or without external beam radiotherapy for oral or oropharyngeal squamous cell carcinomas in previously irradiated areas: carcinologic and toxicity outcom... by Pierre-Marie Pialat, Michael Mounie, Fabien Podeur, Frédéric Gassa, Jean-Philippe Suchaud, Bertrand Fleury, Severine Racadot, Anne-Agathe Serre, Pascal Pommier

    Published 2021-08-01
    Get full text
    Article
  7. 7
    Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy

    Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy by Pierre-Marie Pialat, MD, Maxime Fieux, MD, Stéphane Tringali, MD, PhD, Guillaume Beldjoudi, PhD, Pascal Pommier, MD, PhD, Ronan Tanguy, MD

    Published 2021-07-01
    Get full text
    Article
  8. 8
    Interpretable Machine Learning Model for Locoregional Relapse Prediction in Oropharyngeal Cancers

    Interpretable Machine Learning Model for Locoregional Relapse Prediction in Oropharyngeal Cancers by Paul Giraud, Philippe Giraud, Eliot Nicolas, Pierre Boisselier, Marc Alfonsi, Michel Rives, Etienne Bardet, Valentin Calugaru, Georges Noel, Enrique Chajon, Pascal Pommier, Magali Morelle, Lionel Perrier, Xavier Liem, Anita Burgun, Jean Emmanuel Bibault

    Published 2020-12-01
    Get full text
    Article
  9. 9
    Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer

    Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer by Ingrid Masson, Laurène Larriviere, Marc-André Mahé, David Azria, Pascal Pommier, Nathalie Mesgouez-Nebout, Philippe Giraud, Didier Peiffert, Bruno Chauvet, Philippe Dudouet, Naji Salem, Georges Noël, Jonathan Khalifa, Igor Latorzeff, Catherine Guérin-Charbonnel, Stéphane Supiot

    Published 2024-01-01
    Get full text
    Article
  10. 10
    A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy – including photon and proton therapy – for the treatment of radioresistant tumors: the ETOILE trial

    A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy – including photon and proton therapy – for the treatment of radio... by Jacques Balosso, Olivia Febvey-Combes, Annie Iung, Hélène Lozano, Abdoulkader Soumai Alloh, Catherine Cornu, Magali Hervé, Zohra Akkal, Michel Lièvre, Valérie Plattner, Francesca Valvo, Cristina Bono, Maria Rosaria Fiore, Viviana Vitolo, Barbara Vischioni, Stéphanie Patin, Hubert Allemand, François Gueyffier, Jennifer Margier, Pascale Guerre, Sylvie Chabaud, Roberto Orecchia, Pascal Pommier

    Published 2022-05-01
    Get full text
    Article
  11. 11
    Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol

    Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study... by Maximilien Rogé, Yoann Pointreau, Paul Sargos, Emmanuel Meyer, Ulrike Schick, Ali Hasbini, Emmanuel Rio, Guillaume Bera, Amandine Ruffier, Magali Quivrin, Mathieu Chasseray, Igor Latorzeff, Etienne Martin, Valentine Guimas, Pascal Pommier, Thomas Leroy, Philippe Ronchin, Alexis Lepinoy, Audrey Grand, Lysian Cartier, Ossama Didas, Fabrice Denis, Vincent Libois, Audrey Blanc-Lapierre, Stéphane Supiot

    Published 2023-05-01
    Get full text
    Article

Search Tools: